Identifying molecular markers in non-small cell lung cancer using computer-aided scoring and analysis (CASA)

被引：0

作者：

Shakooria, Abbas ^{[1
,2
]}

Fukuoka, Junya ^{[1
,2
]}

Dracheva, Tatiana ^{[1
,2
]}

Shih, Joanna H. ^{[3
]}

Shilo, Konstantin ^{[5
]}

Nwosu, Uchenna ^{[1
]}

Zhang, Henry ^{[2
]}

Gill, Rajbir ^{[1
]}

Jeon, Hyosung ^{[1
]}

Clifford, Robert ^{[2
]}

Franks, Teri J. ^{[5
]}

Hewitt, Stephen ^{[4
]}

Travis, William ^{[6
]}

Jen, Jin ^{[1
]}

机构：

[1] NCI, Human Carcinogenesis Lab, Ctr Canc Res, Bethesda, MD 20892 USA

[2] NCI, Lab Populat Genet, Ctr Canc Res, Bethesda, MD 20892 USA

[3] NCI, Biometr Res Branch, Ctr Canc Res, Bethesda, MD 20892 USA

[4] NCI, Tissue Array Res Program, Ctr Canc Res, Bethesda, MD 20892 USA

[5] Armed Forces Inst Pathol, Dept Pulm & Mediastinal Pathol, Washington, DC 20306 USA

[6] Mem Sloan Kettering Canc Ctr, Dept Pathol, New York, NY 10021 USA

来源：

CANCER BIOMARKERS | 2008年 / 4卷 / 03期

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：147 / 147

页数：1

共 50 条

[41] Hypoxic markers in non-small cell lung cancer (NSCLC) - A review
Xu, F. -X.
Zhang, Y. -L.
Liu, J. -J.
Zhang, D. -D.
Chen, H. -B.
[J]. EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2016, 20 (05) : 849 - 852
[42] Circulating apoptotic markers in the management of non-small cell lung cancer
Holdenrieder, Stefan
Stieber, Petra
[J]. CANCER BIOMARKERS, 2010, 6 (3-4) : 197 - 210
[43] Serum Glycans as Risk Markers for Non-Small Cell Lung Cancer
Ruhaak, L. Renee
Stroble, Carol
Dai, Jianliang
Barnett, Matt
Taguchi, Ayumu
Goodman, Gary E.
Miyamoto, Suzanne
Gandara, David
Feng, Ziding
Lebrilla, Carlito B.
Hanash, Samir
[J]. CANCER PREVENTION RESEARCH, 2016, 9 (04) : 317 - 323
[44] Histological Markers Associated with Radiosensitivity in Non-Small Cell Lung Cancer
Baena, J. D.
Le Quesne, J. P. C.
Talbot, C. J.
[J]. JOURNAL OF PATHOLOGY, 2017, 241 : S7 - S7
[45] The influence of sex on prognostic markers for non-small cell lung cancer
Paul, Boutros C.
[J]. CANCER RESEARCH, 2010, 70
[46] Impact of Genetic Markers on Treatment of Non-small Cell Lung Cancer
Lamparella, Nicholas
Barochia, Amit
Almokadem, Salah
[J]. IMPACT OF GENETIC TARGETS ON CANCER THERAPY, 2013, 779 : 145 - 164
[47] A Computer - Aided Drug Designing for Pharmacological Inhibition of Mutant ALK for the Treatment of Non-Small Cell Lung Cancer
Sharda, Saphy
Khandelwal, Ravina
Adhikary, Ritu
Sharma, Diksha
Majhi, Manisha
Hussain, Tajamul
Nayarisseri, Anuraj
Singh, Sanjeev Kumar
[J]. CURRENT TOPICS IN MEDICINAL CHEMISTRY, 2019, 19 (13) : 1129 - 1144
[48] Molecular Diagnostic Testing in Non-Small Cell Lung Cancer
Naidoo, Jarushka
Drilon, Alexander
[J]. AMERICAN JOURNAL OF HEMATOLOGY-ONCOLOGY, 2014, 10 (04) : 4 - 11
[49] Molecular biologic substaging of non-small cell lung cancer
D'Amico, TA
[J]. JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 2002, 123 (03): : 409 - 410
[50] The diagnosis of non-small cell lung cancer in the molecular era
Brainard, Jennifer
Farver, Carol
[J]. MODERN PATHOLOGY, 2019, 32 : 16 - 26

← 1 2 3 4 5 →